Page last updated: 2024-09-03

1-naphthylacetylspermine and oxidopamine

1-naphthylacetylspermine has been researched along with oxidopamine in 1 studies

Compound Research Comparison

Studies
(1-naphthylacetylspermine)
Trials
(1-naphthylacetylspermine)
Recent Studies (post-2010)
(1-naphthylacetylspermine)
Studies
(oxidopamine)
Trials
(oxidopamine)
Recent Studies (post-2010) (oxidopamine)
510228,63062,407

Protein Interaction Comparison

ProteinTaxonomy1-naphthylacetylspermine (IC50)oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)8
DNA repair protein RAD52 homologHomo sapiens (human)0.779

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, L; Guo, Y; Li, LB; Liu, J; Sun, YN; Wang, T; Wang, Y; Yao, L; Zhang, J; Zhang, L1

Other Studies

1 other study(ies) available for 1-naphthylacetylspermine and oxidopamine

ArticleYear
Blockade of calcium-permeable AMPA receptors in the lateral habenula produces increased antidepressant-like effects in unilateral 6-hydroxydopamine-lesioned rats compared to sham-lesioned rats.
    Neuropharmacology, 2019, Volume: 157

    Topics: Action Potentials; Animals; Antidepressive Agents; Behavior, Animal; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Dopamine; Dopaminergic Neurons; Dorsal Raphe Nucleus; Habenula; Ibotenic Acid; Male; Neural Inhibition; Oxidopamine; Pars Compacta; Phosphorylation; Prefrontal Cortex; Rats; Receptors, AMPA; Serotonergic Neurons; Serotonin; Spermine; Tegmentum Mesencephali; Ventral Tegmental Area

2019